MBOT Valuation Metrics
FCF$-13.11M
FCF Growth Rate—
EPS Growth (CAGR)—
WACC10.00%
Microbot Medical Inc
Exchange: NASDAQSector: HealthcareIndustry: Medical Instruments & Supplies
Microbot Medical Inc. is a pre-commercial stage medical technology company with a vision to improve the quality of care for millions of patients and providers globally. The Company has developed the world’s first single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems.
Current Price
$1.85
+0.00%Profile
Valuation (TTM)
Market Cap$124.24M
P/E-8.74
EV—
P/B1.60
Shares Out67.16M
P/Sales1183.26
Revenue$105000.00
EV/EBITDA—
Microbot Medical Inc (MBOT) Valuation
Fair Value Models
Graham Number, PEG-based, and Earnings-based models
View Fair Value →MBOT Valuation & Fair Value Analysis
Microbot Medical Inc (MBOT) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The price-to-earnings (P/E) ratio is -8.74. Price-to-book ratio is 1.60. Price-to-sales ratio is 1183.26. PEG ratio is 0.23.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Microbot Medical Inc's intrinsic value.